Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
KR 1020170113585-A2017-10-12
STABILIZED SOLUTION PREPARATION OF PHARMACEUTICAL GLP-1R ANTIBODY FUSION PROTEIN
GMAX BIOPHARM LLC
Query Match 93.2%Identity 96.6%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||||| | Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 3129 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020170113585-A2017-10-12
- JP 2018508571-A2018-03-29
-
US 10485870-B22019-11-26
Stable pharmaceutical solution formulation of GLP-1R antibody fusion protein
Gmax Biopharm LLC.
Query Match 93.2%Identity 96.6%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||||| | Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 3129 of 31 identical, no gaps.
-
KR 1020200133365-A2020-11-27
GIPR ANTIBODY AND GLP-1 FUSION PROTEIN THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
GMAX BIOPHARM LLC
Query Match 93.2%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200133365-A2020-11-27
- JP 2021518132-A2021-08-02
- US 11780916-B22023-10-10
-
EP 3778634-A12021-02-17
GCGR ANTIBODY AND GLP-1 FUSION PROTEIN THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF
GMAX BIOPHARM LLC
Query Match 93.2%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3778634-A12021-02-17
- US 11542336-B22023-01-03
-
KR 1020220063221-A2022-05-17
GIPR ANTIBODY AND FUSION PROTEIN BETWEEN SAME AND GLP-1, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
GMAX BIOPHARM LLC
Query Match 93.2%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 ||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 2929 of 29 identical, no gaps.
Family of 3
Grouped by a shared priority claim, CN 201910882351.2.
- KR 1020220063221-A2022-05-17
- JP 2022549172-A2022-11-24
- JP 2025165930-A2025-11-05
-
WO 2025237364-A12025-11-20
FUSION POLYPEPTIDES AND PREPARATION METHOD AND USE THEREOF
PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD
Query Match 93.2%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||||||||||||| | Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGGG 3129 of 31 identical, no gaps.
-
JP 1992135490-A1992-05-08
DNA CODING CHICKEN GLUCAGON
SHIONOGI & CO LTD
Query Match 92.5%Identity 87.1%
Best alignment
Query 1 to 31, hit 118 to 148. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||| ||| |||||||||||||||| ||| Hit 118 HAEGTYTSDITSYLEGQAAKEFIAWLVNGRG 14827 of 31 identical, no gaps.
-
WO 2004067548-A22004-08-12
Chemically modified metabolites of regulatory peptides and methods of producing and using same
THERATECHNOLOGIES INC. (CA)
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 1 to 29. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 1 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 2929 of 29 identical, no gaps.
-
EP 1701731-A12006-09-20
Glp-1 (9-36) methods and compositions
EINSTEIN COLL MED
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 1 to 29. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 1 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 2929 of 29 identical, no gaps.
-
JP 2013514322-A2013-04-25
GLP-1 receptor agonist compounds with a modified N-terminus
Novo Nordisk A/S
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 1 to 29. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 1 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 2929 of 29 identical, no gaps.
-
KR 1020170004967-A2017-01-11
HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE
CAPON, Daniel J
Query Match 92.5%Identity 93.5%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020170004967-A2017-01-11
- EP 3116486-A22017-01-18
- KR 1020230010667-A2023-01-19
-
JP 2017516839-A2017-06-22
HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE
Daniel J Capon
Query Match 92.5%Identity 93.5%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 61/953650.
- JP 2017516839-A2017-06-22
- US 11066459-B22021-07-20
- JP 2024023196-A2024-02-21
-
WO 2020092191-A12020-05-07
PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME
LILLY CO ELI
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
EP 3701971-A12020-09-02
COMPOUNDS USEFUL IN PREPARING HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE
CAPON DANIEL J
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2021512634-A2021-05-20
FGF21 VARIANT, FUSION PROTEIN AND APPLICATION THEREOF
SUNSHINE LAKE PHARMA CO LTD
Query Match 92.5%Identity 93.5%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2021512634-A2021-05-20
- US 11679143-B22023-06-20
-
KR 1020210071038-A2021-06-15
PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME
Eli Lilly and Company
Query Match 92.5%Identity 93.5%Family of 7
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
Family of 7
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210071038-A2021-06-15
- US 11155592-B22021-10-26
- JP 2022506070-A2022-01-17
- JP 2023082013-A2023-06-13
- US 11820803-B22023-11-21
- KR 1020240093737-A2024-06-24
- US 12269857-B22025-04-08
-
WO 2021231366-A12021-11-18
ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF
REGENERON PHARMA
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 2 to 30. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 2 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3029 of 29 identical, no gaps.
-
KR 1020230009501-A2023-01-17
ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF
REGENERON PHARMACEUTICALS, INC
Query Match 92.5%Identity 100.0%Family of 2
Best alignment and family
Query 3 to 31, hit 2 to 30. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 2 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3029 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230009501-A2023-01-17
- JP 2023526233-A2023-06-21
-
KR 1020230066317-A2023-05-15
TETRAHEDRAL ANTIBODIES
BIOMOLECULAR HOLDINGS LLC
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2023535677-A2023-08-21
Tetrahedral Antibodies
Biomolecular Holdings LLC
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
US 11884736-B22024-01-30
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
Regeneron Pharmaceuticals, Inc.
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 2 to 30. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 2 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3029 of 29 identical, no gaps.
-
EP 4426729-A12024-09-11
SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE
HANGZHOU DAC BIOTECH CO LTD
Query Match 92.5%Identity 87.1%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || ||||||||||| ||||| |||||| ||| Hit 1 HAQGTFTSDVSSYLQGQAAKQFIAWLVRGRG 3127 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, WO2021CN128453.
- EP 4426729-A12024-09-11
- EP 4426741-A12024-09-11
-
EP 4463485-A22024-11-20
TETRAHEDRAL ANTIBODIES
BIOMOLECULAR HOLDINGS LLC
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
JP 2025502229-A2025-01-24
Tetrahedral Antibodies
Biomolecular Holdings LLC
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
EP 4502164-A12025-02-05
GLUCOSE-REGULATED GENE EXPRESSION LOOP CONTROL SYSTEM AND USE THEREOF IN REGULATING AND CONTROLLING BLOOD GLUCOSE
UNIV EAST CHINA NORMAL
Query Match 92.5%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||| ||||||| ||| Hit 1 HSEGTFTSDVSSYLEGQAAQEFIAWLVNGRG 3128 of 31 identical, no gaps.
-
US 12421317-B22025-09-23
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
Regeneron Pharmaceuticals, Inc.
Query Match 92.5%Identity 100.0%
Best alignment
Query 3 to 31, hit 2 to 30. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| Hit 2 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3029 of 29 identical, no gaps.
-
US 12473363-B22025-11-18
NK/monocyte engagers
Biomolecular Holdings LLC
Query Match 92.5%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| ||||||||||||||| Hit 1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKGRG 3129 of 31 identical, no gaps.
-
US 10660939-B22020-05-26
Therapies for obesity, diabetes and related indications
Palatin Technologies, Inc.
Query Match 91.9%Identity 83.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 || ||||| ||||| | ||| ||||||||| Hit 1 HAZGTFTSBVSSYLZGZAAKZFIAWLVKGR 3025 of 30 identical, no gaps.
-
KR 1020230129425-A2023-09-08
THERAPEUTIC REGIMENS AND METHODS FOR LOWERING BLOOD GLUCOSE AND OR BODY WEIGHT USING GLP-1R AND GCGR BALANCED AGONISTS
SPITFIRE PHARMA, LLC
Query Match 91.9%Identity 90.3%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||| ||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAXEFIAWLVRGRG 3128 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230129425-A2023-09-08
- JP 2024500324-A2024-01-09
- US 12171806-B22024-12-24
-
JP 2025526148-A2025-08-07
COMBINATION THERAPY COMPRISING LONG ACTING GLP-1/GLUCAGON AND NPY2 RECEPTOR AGONISTS
Boehringer Ingelheim International GmbH
Query Match 91.9%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | ||||||||||||||||||||||||| || Hit 1 HXEGTFTSDVSSYLEGQAAKEFIAWLVRGR 3028 of 30 identical, no gaps.
-
EP 4808963-A12026-09-23
SYNTHETIC GLP-1R BINDING PROTEINS, MANUFACTURE, AND USES THEREOF
AI PROTEINS INC
Query Match 91.9%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||| ||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAAXEFIAWLVRGRG 3128 of 31 identical, no gaps.
-
US 7897566-B22011-03-01
Analogues of GLP-1
Ipsen Pharma S.A.S.
Query Match 91.3%Identity 100.0%
Best alignment
Query 2 to 30, hit 2 to 30. Positions start at 1 and include both ends.
Query 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 ||||||||||||||||||||||||||||| Hit 2 AEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3029 of 29 identical, no gaps.
-
US 8497356-B22013-07-30
Biomolecule polymer conjugates and methods for making the same
Duke University
Query Match 91.3%Identity 96.7%
Best alignment
Query 1 to 30, hit 8 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||| ||||||||||||||||| Hit 8 HAEGTFTSDVSSVLEGQAAKEFIAWLVKGR 3729 of 30 identical, no gaps.
-
WO 2017180988-A22017-10-19
FGF21 C-TERMINAL PEPTIDE OPTIMIZATION
UNIV INDIANA RES & TECH CORP
Query Match 91.3%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||| ||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEEQAAREFIAWLVRGRG 3128 of 31 identical, no gaps.
-
WO 2019207505-A12019-10-31
GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF
JANSSEN PHARMACEUTICA NV
Query Match 91.3%Identity 93.3%Family of 5
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | ||||||||||||||||||||| |||||| Hit 1 HSEGTFTSDVSSYLEGQAAKEFIEWLVKGR 3028 of 30 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019207505-A12019-10-31
- US 10875902-B22020-12-29
- KR 1020210005674-A2021-01-14
- JP 2021522258-A2021-08-30
- JP 2025118735-A2025-08-13
-
US 11351268-B22022-06-07
FGF21 C-terminal peptide optimization
Indiana University Research and Technology Corporation
Query Match 91.3%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||| ||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEEQAAREFIAWLVRGRG 3128 of 31 identical, no gaps.
-
US 11780900-B22023-10-10
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
Janssen Sciences Ireland Unlimited Company
Query Match 91.3%Identity 93.3%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 | ||||||||||||||||||||| |||||| Hit 1 HSEGTFTSDVSSYLEGQAAKEFIEWLVKGR 3028 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 11780900-B22023-10-10
- EP 4640701-A22025-10-29
-
EP 4731245-A12026-04-29
USE OF A LONG-ACTING OXYNTOMODULIN DERIVATIVE FOR TREAMENT OF FATTY LIVER DISEASE
MERCK SHARP & DOHME LLC
Query Match 91.3%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||| ||||||| ||| Hit 1 HXEGTFTSDVSSYLEGQAALEFIAWLVRGRG 3128 of 31 identical, no gaps.
-
EP 4774397-A12026-07-15
GENETIC ELEMENTS FOR ADJUSTMENT OF EXPRESSION
REMEDIUM BIO INC
Query Match 91.3%Identity 90.3%
Best alignment
Query 1 to 31, hit 48 to 78. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||||||| ||||||| ||| Hit 48 HGEGTFTSDVSSYLEGQAAQEFIAWLVDGRG 7828 of 31 identical, no gaps.
-
WO 2004087910-A2004-10-14
The production method of plant storage organ that recombinant protein is high-producted and novel recombinant protein
NIPPON PAPER CO LTD,National Institute of Agrobiological Sciences, SANWA KAGAKU KENKYUSHO CO LTD, Bio-oriented Technology Research Advancement Institution
Query Match 90.7%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 ||||||||||||||||||| ||||||| || Hit 1 HAEGTFTSDVSSYLEGQAAQEFIAWLVNGR 3028 of 30 identical, no gaps.
-
US 7662771-B22010-02-16
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
Emisphere Technologies, Inc.
Query Match 90.7%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||| ||||||||||||| ||||||||| Hit 1 HAEGTFTVDVSSYLEGQAAKEEIAWLVKGRG 3129 of 31 identical, no gaps.
-
EP 2256189-A12010-12-01
Process for producing a plant storage organ in which a GLP-1 derivative recombinant protein is highly produced.
NAT INST OF AGROBIO SCIENCES
Query Match 90.7%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 ||||||||||||||||||| ||||||| || Hit 1 HAEGTFTSDVSSYLEGQAAQEFIAWLVNGR 3028 of 30 identical, no gaps.
-
US 9487570-B22016-11-08
Glucagon like peptide analogs, composition, and method of use
BETTA PHARMACEUTICALS CO., LTD
Query Match 90.7%Identity 100.0%
Best alignment
Query 3 to 31, hit 1 to 29. Positions start at 1 and include both ends.
Query 3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||| ||| Hit 1 EGTFTSDVSSYLEGQAAKEFIAWLVRGRG 2928 of 29 identical, no gaps.
-
JP 2017526620-A2017-09-14
APELIN POLYPEPTIDES
AMGEN INC
Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAK-EFIAWLVKGRG 31 |||||||||||||||||||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKXEFIAWLVRGRG 3230 of 32 identical, 1 gap.
-
KR 1020210006301-A2021-01-18
A novel fusion protein and use thereof
PROGEN CO., LTD
Query Match 90.7%Identity 96.6%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 | ||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKG 2928 of 29 identical, no gaps.
-
US 10941182-B22021-03-09
Apelin polypeptides
Amgen Inc.
Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAK-EFIAWLVKGRG 31 |||||||||||||||||||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKXEFIAWLVRGRG 3230 of 32 identical, 1 gap.
-
KR 1020210109552-A2021-09-06
BISPECIFIC PROTEIN
JIANGSU HENGRUI MEDICINE CO.,LTD.
Query Match 90.7%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| |||||||||||||| Hit 1 HGEGTFTSDVSSYLEEEAAKEFIAWLVKGRG 3128 of 31 identical, no gaps.
-
JP 2022028961-A2022-02-16
APELIN POLYPEPTIDES
AMGEN INC
Query Match 90.7%Identity 93.8%
Best alignment
Query 1 to 31, hit 1 to 32. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAK-EFIAWLVKGRG 31 |||||||||||||||||||| ||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKXEFIAWLVRGRG 3230 of 32 identical, 1 gap.
-
JP 2022516439-A2022-02-28
Bispecific protein
JIANGSU HENGRUI MEDICINE CO LTD,SHANGHAI HENGRUI PHARMACEUTICAL CO LTD
Query Match 90.7%Identity 90.3%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 | ||||||||||||| |||||||||||||| Hit 1 HGEGTFTSDVSSYLEEEAAKEFIAWLVKGRG 3128 of 31 identical, no gaps.
-
KR 1020220080221-A2022-06-14
A novel modified immunoglobulin Fc fusion protein and use thereof
PROGEN CO., LTD
Query Match 90.7%Identity 96.6%Family of 3
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29 | ||||||||||||||||||||||||||| Hit 1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKG 2928 of 29 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/847470.
- KR 1020220080221-A2022-06-14
- JP 2022532414-A2022-07-14
- JP 2024061734-A2024-05-08